p19Arf sensitizes B16 melanoma cells to interferon-β delivered via mesenchymal stem cells in vitro

The immune stimulatory and anti-neoplastic functions of type I interferon have long been applied for the treatment of melanoma. However, the systemic application of high levels of this recombinant protein is often met with toxicity. An approach that provides localized, yet transient, production of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Da-Costa, R.C., Vieira, I.L., Hunger, A., Tamura, R.E., Strauss, B.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025448/
https://www.ncbi.nlm.nih.gov/pubmed/32077463
http://dx.doi.org/10.1590/1414-431X20198876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025448/
https://www.ncbi.nlm.nih.gov/pubmed/32077463
http://dx.doi.org/10.1590/1414-431X20198876

Ejemplares similares